Abstract
Aims Hb Toranomon [β112 (G14) Cys → Try] was the variant hemoglobin first reported by Harano et al. (Hemoglobin 20:361–369, 1996). Since 2004 there have been successive reports of Hb Toranomon based on abnormal HbA1c levels measured by high-performance liquid chromatography (HPLC). HbA1c levels are known to vary depending on the HPLC model used. We compared the HbA1c measured by new and old HPLC models in patients with Hb Toranomon.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
